Brief: Oncolys Biopharma signs memorandum with Jiangsu Hengrui Medicine

Oncolys Biopharma

20/05/2016 07:11

May 20 (Reuters) - Oncolys Biopharma  4588.T : 
     
    * Says it signed a memorandum with Jiangsu Hengrui Medicine 
for distribution of its OBP-301 in China 
    * Says OBP-301 is a limit growth type oncolytic virus 
     
     
    Source text in Japanese: http://985.so/zuj6   
    Further company coverage: 4588.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com;)(+86 010 
62674724;)(Reuters 
Messaging:)(shuai.liu.reuters.com@reuters.net)) 
 
Keywords: ONCOLYS BIOPHARMA/BRIEF